Intrinsic, management, and nutritional factors associated with equine motor neuron disease

Journal of the American Veterinary Medical Association

Volumn 211, Issue 10, 1997, Pages 1261-1267

  De La Rúa Domènech, Ricardo ^a,b   Mohammed, Hussni O ^a   Cummings, John F ^a   Divers, Thomas J ^a   De Lahunta, Alexander ^a   Summers, Brian A ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

ALPHA TOCOPHEROL; SELENIUM;

AGING; ALPHA TOCOPHEROL DEFICIENCY; ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; ARTICLE; BREEDING; CASE CONTROL STUDY; DIET SUPPLEMENTATION; ENVIRONMENT; FEMALE; HORSE; HORSE DISEASE; MALE; MOTOR NEURON DISEASE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK FACTOR;

AGING; ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; BREEDING; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; ENVIRONMENT; FEMALE; HORSE DISEASES; HORSES; MALE; MOTOR NEURON DISEASE; OXIDATIVE STRESS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SELENIUM; VITAMIN E; VITAMIN E DEFICIENCY;

EID: 0031572990     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cummings JF, de Lahunta A, George C, et al. Equine motor neuron disease: a preliminary report. Cornell Vet 1990;80:357-379.
2. Cummings JF, de Lahunta A, Mohammed HO, et al. Equine motor neuron disease: a new neurologic disorder. Equine Pract 1991;13:15-18.
3. Divers TJ, Mohammed HO, Cummings JF, et al. Equine motor neuron disease: a new cause of weakness, trembling and weight loss. Compend Contin Educ Pract Vet 1992;14:1222-1226.
4. Podell M, Valentine BA, Cummings JF, et al. Electromyography in acquired equine motor neuron disease. Prog Vet Neurol 1995;6:128-134.
5. Mohammed HO, Cummings JF, Divers TJ, et al. Risk factors associated with equine motor neuron disease: a possible model for human MND. Neurology 1993;43:966-971.
6. de la Rúa-Domènech R, Mohammed HO, Atwill ER, et al. Epidemiologic evidence for clustering of EMND in the United States. Am J Vet Res 1995;11:1433-1439.
7. Lofsted J, Ikede BO. Motor neuron disease in a quarter horse from Nova Scotia. Can Vet J 1994;35:507-509.
8. Sustronck B, Deprez P, van Roy M, et al. Equine motor neuron disease: the first confirmed cases in Europe. Vlaams Diergeneesk T 1993;62:40-44.
9. Gruys E, Beynen AC, Binkhorst GJ, et al. Neurodegeneratieve aandoeningen van het centrale zenuwstelsel bij het paard. Tijdschr Diergeneeskd 1994;119:561-567.
10. Prendergast M, Basset HF, Cummings JF. Equine motor neuron disease (lett). Vet Rec 1994;135:146.
11. Hahn CN, Mayhew IG. Does equine motor neuron disease exist in the United Kingdom? Vet Rec 1993;132:133-134.
12. Falzer R, Straub R, Gerber V, et al. Sind equine motorische nervenzell-degeneration (EMND) und graskranheit des pferdes unterschiedliche manifestationen der gleichen grundkrankheit? Pferdeheilkunde 1995;11:17-29.
13. Kuwamura M, Iwaki M, Yamate J, et al. The first case of equine motor neuron in Japan. J Vet Med Sci 1994;56:195-197.
14. Amorim RM, Kuchembuck MRG, Goncalves RC, et al. Equine motor neuron disease. Report on the first cases in South America. Braz J Vet Res Anim Sci 1996;33:47-52.
15. de la Rúa-Domènech R, Mohammed HO, Cummings JF, et al. Incidence and risk factors of equine motor neuron disease: an ambidirectional study. Neuroepidemiology 1995;14:54-64.
16. Divers TJ, Mohammed HO, Cummings JF, et al. Equine motor neuron disease: findings in 28 horses and proposal of a pathophysiological mechanism for the disease. Equine Vet J 1994;26:409-415.
17. Valentine BA, de Lahunta A, George C, et al. Acquired equine motor neuron disease. Vet Pathol 1994;31:130-138.
18. Cummings JF, de Lahunta A, Mohammed HO, et al. Endothelial lipopigment as an indicator of a-tocopherol deficiency in two equine neurodegenerative disorders. Acta Neuropathol (Berl) 1995;90:266-272.
19. Blythe LL, Craig AM. Equine degenerative myeloencephalopathy. Compend Contin Educ Pract Vet 1992;14:1215-1221.
20. Dixon WJ. Stepwise logistic regression. In: BMDP statistical software manual. Berkeley, Calif: University of California Press, 1992;1105-1144.
21. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989.
22. Schlesselman JJ. Research strategies. In: Case-control studies. New York: Oxford University Press, 1982;7-26.
23. Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins. Vitamins E and C, beta-carotene and other carotenoids. Ann N Y Acad Sci 1992;669:7-20.
24. Kapper DR. Elements of nutrition: a primer for practitioners, in Proceedings. Annu Meet Am Assoc Equine Pract 1992;38:669-679.
25. Hintz HF. Nutrient requirements. In: Robinson NE, ed. Current therapy in equine medicine. Philadelphia: WB Saunders Co, 1992;715-716.
26. Hintz HF. Nutrition and equine performance. J Nutr 1994;124:2723S-2729S.
27. Saastamoinen MT, Juusela J. Serum vitamin E concentration in horses on different vitamin E supplementation levels. Acta Agric Scand Anim Sci 1993;43:52-57.
28. Schryver HF, Hintz HF. Vitamins. In: Robinson NE, ed. Current therapy in equine medicine. Philadelphia: WB Saunders Co, 1987;405-412.
29. McMeniman NP, Hintz HF. Effect of vitamin E status on lipid peroxidation in exercised horses. Equine Vet J 1992;24:482-484.
30. Siciliano PD, Wood CH. The effect of added dietary soybean oil on vitamin E status in the horse. J Anim Sci 1993;71:3399-3402.
31. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-1623.
32. Soave O, Dan Brand C. Coprophagy in animals: a review. Cornell Vet 1991;81:357-364.
33. Mayhew IG. Tetraparesis, paraparesis and ataxia of the limbs, and episodic weakness. In: Large animal neurology. Philadelphia: Lea & Febiger, 1989;294-296.
34. Dill SG, Correa MT, Erb HN, et al. Factors associated with the development of equine degenerative myeloencephalopathy. Am J Vet Res 1990;51:1300-1305.
35. Mayhew IG, Brown CM, Stowe HD, et al. Equine degenerative myeloencephalopathy: a vitamin E deficiency that may be familial. J Vet Intern Med 1987;1:45-50.
36. Brown RH. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995;80:687-692.
37. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neural 1996;39:147-157.
38. Gerber H. Equine motor neuron disease and grass sickness (lett). Vet Rec 1994;135:440.
39. Gilmour JS. Equine dysautonomia: epidemiology and pathology. Proceedings of the Waltham symposium. J Small Anim Pract 1987;28:373-377.
40. Doxey DL, Gilmour JS, Milne EM. A comparative study of normal equine populations and those with grass sickness (dysautonomia) in eastern Scotland. Equine Vet J 1991;23:365-369.
41. Doxey DL, Milne EM, Gilmour JS, et al. Clinical and biochemical features of grass sickness (equine dysautonomia). Equine Vet J 1991;23:360-364.